ESTEVE CDMO expands its presence in Asia with a major investment and new manufacturing site in China

 ・After more than two decades in China, ESTEVE CDMO marks a new chapter in its commitment to the country and the region.
・With more than $80 million invested, the new facility brings a new generation of manufacturing capabilities, with 250 m³ of reaction volume and potential capacity of more than 400+ m³.
・Advanced manufacturing, automation, and digitalization enhance ESTEVE CDMO's capabilities and support its continued growth in Asia. SHAOXING, China, Oct. 21, 2026 /PRNewswire/ -- ESTEVE CDMO, Esteve Healthcare contract development and manufacturing organization, is strengthening i…READ FULL ARTICLE